FDA shear flow instrument system

The contract seeks the acquisition of a shear flow instrument system specifically designed to replicate in vivo conditions for the evaluation of human platelets and red blood cells within their physiological environment. This system is intended to support the FDA's research and analysis efforts by providing precise mimicry of blood flow conditions to enhance the understanding of cellular behavior under shear stress. Issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, this total small business set-aside contract falls under NAICS code 334516, which pertains to manufacturing related to measurement and analytical instruments. The solicitation was posted on June 9, 2026, with a response deadline of June 16, 2026. The contract will be managed from Rockville, Maryland, and the point of contact for inquiries is Tim Walbert. The procurement emphasizes engagement with small businesses to fulfill the agency's technical requirements.